Varian brand Varian ARIA Oncology Information System, Import Export application, v 11.0; Referen...

FDA Device Recall #Z-2153-2012 — Class II — July 2, 2012

Recall Summary

Recall Number Z-2153-2012
Classification Class II — Moderate risk
Date Initiated July 2, 2012
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Varian Medical Systems, Inc. Oncology Systems
Location Palo Alto, CA
Product Type Devices
Quantity 2 Units.

Product Description

Varian brand Varian ARIA Oncology Information System, Import Export application, v 11.0; Reference/FSCA Identifier: CP-08847; Model Number: HIT; Product is manufactured and distributed by Varian Medical Systems Inc., Palo Alto, CA The ARIA Radiation Oncology product is a treatment plan and image management application. It enables the authorized user to enter, access, modify, store and archive treatment plan and image data from diagnostic studies, treatment planning, simulation, plan verification and treatment. ARIA Radiation Oncology also stores the treatment histories including dose delivered to defined sites and provides tools to verify performed treatments. ARIA also includes optional tools to manage the oncology department's clinical and business information.

Reason for Recall

A software anomaly has been identified with the Import Export Application version 11.0 where MLC leaf positions for plans using BrainLab m3 and mMLC are incorrectly imported.

Distribution Pattern

Nationwide Distribution including the states of New York and Ohio.

Lot / Code Information

Serial Numbers/CODES: HIT0535, HIT2953

Other Recalls from Varian Medical Systems, Inc. Oncology...

Recall # Classification Product Date
Z-1163-2013 Class II Varian brand RPM Respiratory Gating System, RPM... Mar 26, 2013
Z-0867-2013 Class II Varian Eclipse Treatment Planning System for Ra... Jan 28, 2013
Z-0531-2013 Class II Varian brand ARIA Radiation Oncology, ARIA Onco... Nov 5, 2012
Z-0187-2013 Class II ARIA Radiation Oncology, Version 11. Varian Med... Sep 24, 2012
Z-2462-2012 Class II Varian brand Eclipse Treatment Planning System,... Aug 17, 2012

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.